Shire launches phosphate binder adherence program for patients
Shire Pharmaceuticals has launched On Track, a program designed to improve adherence to disease management regimens dialysis patients with hyperphosphatemia, or elevated levels of phosphorus in the blood. On Track was designed to provide resources to patients, healthcare professionals and renal care teams that can help them identify "real world" solutions to adherence-related challenges.
Approximately half of all end-stage renal disease patients fail to attain serum phosphorus control, according to Shire. Up to 73 percent of patients are repeatedly non-compliant to phosphate binder therapy. Specifically, 30 percent of patients have decided not to fill one or more prescriptions due to medication costs and/or lack of transportation to the pharmacy, while 21 percent of ESRD patients admit to not taking medications as prescribed due to side effects, cost, and the belief that they already take "too many" medications. ESRD patients are prescribed an average of 12 different medications for concurrent medical conditions.
"Nonadherence to phosphate binder therapy is a serious problem and has become a growing issue among CKD Stage 5 patients due to the complexity of managing the condition," said William Finn, MD, professor of Medicine, University of North Carolina School of Medicine at Chapel Hill. "It is vital for patients to work with their renal care teams to identify successful adherence strategies, as well as to utilize programs and resources available, to address the myriad of reasons that contribute to nonadherence, in order to realize the full benefit of their medications."
On Track will provide resources and services developed with insights from experts in the nephrology and behavior modification fields to help renal care teams and patients take a multifaceted approach to hyperphosphatemia control. Shire also is offering additional support specifically for Fosrenol (Shire's phosphate binder) patients through its comprehensive offerings in Fosrenol On Track—an additional program that offers an array of services to help renal care teams and patients improve adherence.
Fosrenol On Track - Bookshelf
On writing, a memoir of the craft
The author of The Stand, The Shining, and other great books shares his insights into the craft of writing, offering a breezy, humorous perspective on his own ...On the Road, The Original Scroll
A reproduction of Kerouac's original 1951 scroll draft of "On the Road" offers insight into the writer's thematic vision and narrative voice as influenced by ...On photography
A collection of acclaimed essays explores the aesthetic and moral problems raised by the presence and authority of the photographic image in modern-day life, ...On writing well, the classic guide to writing nonfiction
With more than a million copies sole, this volume has stood the test of time and remains a valuable resource for writers and would-be writers.Stumbling on happiness
A smart, witty, accessible, and laugh-out-loud funny reflection on human nature brilliantly describes all that science has to tell us about the uniquely human ...Daily Information Directory
FOSRENOL On Track
Official FOSRENOL® (lanthanum carbonate) homepage
Information from Shire about the medication and its use in the treatment of hyperphosphatemia. Site includes condition management and care provider resources.
Shire To Increase Adherence Among Chronic Kidney Disease Patients
Shire Pharmaceuticals launched On Track, an innovative program designed to improve adherence to disease management regimens among chronic kidney disea...
Shire Looks to Keep Patients On Track
On Track was designed to provide resources to patients, healthcare ... Shire established the Fosrenol On Track hotline to provide a simple, single point of ...
WARNING LETTER
Furthermore, the effect of Fosrenol on the absorption of. vitamins and ... the effect of treatment with Fosrenol on prevention of mineral deposition, bone ...